These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4987349)

  • 41. [Allpurinol in the treatment of hyperuricemia and chronic gout].
    Benedetti A; Nardini A; Busonera G
    Rev Clin Esp; 1969 Mar; 112(6):141-54. PubMed ID: 5347028
    [No Abstract]   [Full Text] [Related]  

  • 42. [Renal physiopathology of uric acid. Pharmacologic study].
    Muñoz Sanz A; García Puig J; Mateos F; Barbado FJ
    Med Clin (Barc); 1982 Jan; 78(2):70-4. PubMed ID: 7070134
    [No Abstract]   [Full Text] [Related]  

  • 43. The dual actions of Paederia scandens extract as a hypouricemic agent: xanthine oxidase inhibitory activity and uricosuric effect.
    Yan H; Ma Y; Liu M; Zhou L
    Planta Med; 2008 Sep; 74(11):1345-50. PubMed ID: 18729039
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of ureogenesis by two hypouricemic drugs (probenecid and benzbromarone). Comparison with allopurinol.
    Sanchez-Beltran MJ; Rodilla F; Gomez-Ruiz MD; Izquierdo R; Cabo J
    Cell Mol Biol; 1988; 34(6):649-54. PubMed ID: 3219699
    [No Abstract]   [Full Text] [Related]  

  • 45. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Uric acid behavior and significance of xanthineoxidase inhibition by allopurinol in tourniquet shock of the dog].
    Brückner UB; Opherk D; Schmier J; Treumer H
    Z Kardiol; 1973 Sep; 62(9):870-81. PubMed ID: 4767210
    [No Abstract]   [Full Text] [Related]  

  • 47. THE EFFECTIVENESS OF THE XANTHINE OXIDASE INHIBITOR ALLOPURINOL IN THE TREATMENT OF GOUT.
    KLINENBERG JR; GOLDFINGER SE; SEEGMILLER JE
    Ann Intern Med; 1965 Apr; 62():639-47. PubMed ID: 14274828
    [No Abstract]   [Full Text] [Related]  

  • 48. Xanthine nephropathy in a patient with lymphosarcoma treated with allopurinol.
    Band PR; Silverberg DS; Henderson JF; Ulan RA; Wensel RH; Banerjee TK; Little AS
    N Engl J Med; 1970 Aug; 283(7):354-7. PubMed ID: 5468406
    [No Abstract]   [Full Text] [Related]  

  • 49. [Allopurinol].
    Scott JT
    Schweiz Med Wochenschr; 1967 Dec; 97(49):1659-62. PubMed ID: 5596893
    [No Abstract]   [Full Text] [Related]  

  • 50. Inhibition of purine catabolism by benzbromarone in isolated rat liver cells. Comparison with allopurinol and probenecid.
    Rodilla F; Sanchez-Beltran MJ; Izquierdo R; Gomez-Ruiz MD; Cabo J
    Biochem Pharmacol; 1988 Oct; 37(19):3561-3. PubMed ID: 3178870
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Allopurinol in the prevention of hyperuricaemia secondary to the treatment of neoplastic diseases with alkylating agents, adrenal steroids, and radiation therapy.
    Krakoff IH; Balis ME
    Ann Rheum Dis; 1966 Nov; 25(6 Suppl):651-4. PubMed ID: 5958695
    [No Abstract]   [Full Text] [Related]  

  • 52. A crossover study of allopurinol administration to a schizophrenic child.
    Coleman M
    J Autism Child Schizophr; 1974 Sep; 4(3):231-40. PubMed ID: 4613729
    [No Abstract]   [Full Text] [Related]  

  • 53. Mechanisms of antihyperuricemic effect of Phyllanthus niruri and its lignan constituents.
    Murugaiyah V; Chan KL
    J Ethnopharmacol; 2009 Jul; 124(2):233-9. PubMed ID: 19397979
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Uricosuric effect of irtemazole in healthy subjects.
    Gresser U; Zöllner N
    Klin Wochenschr; 1989 Oct; 67(19):971-5. PubMed ID: 2615290
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antihyperuricemic lignans from the leaves of Phyllanthus niruri.
    Murugaiyah V; Chan KL
    Planta Med; 2006 Nov; 72(14):1262-7. PubMed ID: 16953466
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Maintenance therapy of gout].
    Hart FD
    Clin Ter; 1967 Mar; 40(6):511-9. PubMed ID: 5601192
    [No Abstract]   [Full Text] [Related]  

  • 57. Xanthine oxidase inhibitors: an emerging class of drugs for heart failure.
    Kittleson MM; Hare JM
    Eur Heart J; 2005 Aug; 26(15):1458-60. PubMed ID: 15917281
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of xanthine oxidase inhibition in cardiac arrest.
    Parker JC; Smith EE
    Surgery; 1972 Mar; 71(3):339-44. PubMed ID: 5010215
    [No Abstract]   [Full Text] [Related]  

  • 59. Schiff base transition metal complexes as novel inhibitors of xanthine oxidase.
    You ZL; Shi DH; Xu C; Zhang Q; Zhu HL
    Eur J Med Chem; 2008 Apr; 43(4):862-71. PubMed ID: 17706325
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Treatment of gouty purine metabolism disorder with mercapto-pyrazolo-pyrimidine (thiopurinol)].
    Delbarre F; Auscher C; de Gery A; Brouilhet H; Olivier JL
    Presse Med (1893); 1968 Dec; 76(49):2329. PubMed ID: 5737251
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.